Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-10-000024)

Filing Details

Accession Number:: 0000711377-10-000024
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-10-05 09:36:51
Reporting Period:: 2010-10-01

Filing Date:: 2010-10-05
Accepted Time:: 2010-10-05 09:36:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1188979	C Jack Parnell			Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-10-01	4,015	$8.18	37,065	No	4	M	Direct
Common Stock	Disposition	2010-10-01	4,015	$32.97	33,050	No	4	S	Direct
Common Stock	Acquisiton	2010-10-01	3,685	$9.02	36,735	No	4	M	Direct
Common Stock	Disposition	2010-10-01	3,685	$32.97	33,050	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Option (Right to buy)	Disposition	2010-10-01	4,015	$0.00	4,015	$8.18
Common Stock	Common Stock Option (Right to buy)	Disposition	2010-10-01	3,685	$0.00	3,685	$9.02

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,502		2015-10-31	No	4	M	Direct
6,817		2016-11-03	No	4	M	Direct

Footnotes

The options were granted 10/31/05 as NQ options and became exercisable 33% yearly thereafter
The options were granted 11/3/06 as NQ options and became exercisable 33% yearly thereafter.